The decision indicates a growing certainty that the Games will go on, despite months of concern that they could become a superspreader event. Here’s the latest on the pandemic.

Clinical trial populations are often not proportionate to populations affected by the disease
U.S. researchers—who only a half century ago largely excluded women from clinical trials—now ensure they comprise half the study participants in National Institutes of Health-funded research.
Best Prime Day AirPods deals for 2021
Prime Day has arrived, and we’re seeing some great Prime Day AirPods deals — check them out here.
Best Prime Day projector deals for 2021
With Prime Day having finally arrived, we’ve checked all the best Prime Day projector deals and rounded them up for you here.
Best Prime Day Roku deals for 2021
Looking to add streaming capabilities to your TV? Check out these great Prime Day Roku deals up for grabs now.

UK citizens of South Asian heritage most likely minority ethnic group to choose COVID vaccination
People of South Asian origin are the most likely of all Britain’s minority ethnic communities to agree to COVID-19 vaccination—the safest way to reach population immunity, a new study reveals.
This is the best place to buy a Dell laptop this Amazon Prime Day
The best place to find hot Prime Day deals on Dell laptops isn’t Amazon — it’s Dell’s own Prime Day sale.

New Zealand weightlifter to become first transgender athlete at Olympic Games
New Zealand weightlifter Laurel Hubbard is set to become the first transgender athlete to compete in the Olympic Games, after she was selected for the national team on Monday.

Tucker Carlson Calls Journalists ‘Animals.’ He’s Also Their Best Source.
His platform on Fox News made him a big player in Donald Trump’s circle. Off camera, he shapes the coverage of Trump’s world and Fox’s own internal politics.

COVID vaccination has turned into a ‘battle of the brands’. But not everyone’s buying it
When we were hanging out for a COVID-19 vaccine in 2020, it was a bit like a horse race. We asked ourselves which vaccine would get over the line to win, and how quickly. Then, as multiple vaccines began reporting results from clinical trials, the race turned to which could offer superior efficacy and safety.